Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03507010 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ledderhose Disease: Radiotherapy or Not?

Study acronym: LedRad
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion date: Jan 15, 2026 to Mar 15, 2029v5
  2. Completion date: Aug 15, 2021 to Jan 15, 2026v4
  3. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 80 to confirmed 84 · Primary and study completion dates: Apr 15, 2021 to Aug 15, 2021 · Site details revisedv3 Show 3 more changesShow less
    • Enrollment target: estimated 80 to confirmed 84
    • Primary and study completion dates: Apr 15, 2021 to Aug 15, 2021
    • Site details revised
  4. Start date: Dec 1, 2017 to Jan 23, 2018 Collaborators: 4 to 3v2 Show 1 more changeShow less
    • Collaborators: 4 to 3

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the LedRad trial is to determine the efficacy and durability of radiotherapy as treatment for patients with Ledderhose disease and to compare this to the natural course of Ledderhose disease.
Trial Details
NCT Number NCT03507010
Lead Sponsor University Medical Center Groningen
Collaborators: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Catharina Ziekenhuis Eindhoven, Rijnstate Hospital
Conditions Ledderhose Disease
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov